Related Experiment Videos
Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain
J Schoepfer1, B Gay, G Caravatti
1Novartis Pharma Inc., Oncology Research Department, Basle, Switzerland.
Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
Abstract:
We have designed and synthesized a (3-aminomethyl-phenyl)-urea scaffold to mimic the X+1-Asn part of the minimal phosphopeptide sequence, Ac-pTyr-X+1-Asn-NH2, recognized by the Grb2-SH2 domain. The resulting compounds show the same degree of affinity as their peptide counterparts for the Grb2-SH2 domain. This is the first example reported to date of ligands of the Grb2-SH2 domain with substantially reduced peptidic character.